The Hematology of Tomorrow Is Here—Preclinical Models Are Not: Cell Therapy for Hematological Malignancies

SIMPLE SUMMARY: Cell therapy is revolutionizing the prospect of deadly hematological malignancies such as high-risk acute myeloid leukemia. Stem cell therapy of allogeneic source from compatible human leukocyte antigen donor has exceptional success promoting durable remissions, but the rate of relap...

Descripción completa

Detalles Bibliográficos
Autor principal: Arranz, Lorena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833715/
https://www.ncbi.nlm.nih.gov/pubmed/35158848
http://dx.doi.org/10.3390/cancers14030580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833715/
https://www.ncbi.nlm.nih.gov/pubmed/35158848
http://dx.doi.org/10.3390/cancers14030580

Ejemplares similares